arrow
M

Matti Aapro

Clinique de Genolier
H指数:103
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study Group

定义并应对癌症老年患者的孤独感:来自多国癌症支持治疗协会姑息治疗组国际Delphi共识

2026-01-070
OAAI
Improving communication between healthcare professionals and patients living with advanced breast cancer: a global expert review and call-to-action for 2025–2035 (Goal 5)

改善医疗保健专业人员与晚期乳腺癌患者之间的沟通:一项全球专家回顾与2025–2035年行动计划(目标5)

2025-11-060
OAAI
Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9)

改善晚期乳腺癌患者获得综合护理的公平性:一项全球专家评审和2025-2035年行动计划(目标9)

BREAST
IF7.9
2025-11-010
OAAI
Personalised Antiemetic Prophylaxis with NEPA for Patients at High-Risk of Chemotherapy-induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: Results from the Randomised, Multinational MyRisk Trial

基于NEPA的个性化抗恶心预防方案用于接受中度致吐性化疗的高危化疗诱导恶心呕吐患者的疗效:随机、多国MyRisk试验结果

2025-10-170
PRE
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

6th和7th晚期乳腺癌管理国际共识指南 (ABC指南6和7)

BREAST
IF7.9
2024-08-0122
OAAI
Tailoring neo/adjuvant systemic therapy in breast cancer: The advent of a personalized approach-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations

定制乳腺癌的新/辅助系统治疗: 个性化方法的出现-乳腺妇科和免疫肿瘤学国际癌症会议 (BGICC) 共识和建议

CANCER
IF5.1
2024-07-100
PRE
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes

HER2-Directed曲妥珠单抗生物仿制药Ogivri的真实世界症状和健康报告与赫赛汀治疗乳腺癌的注册数据的比较: 电子患者报告结果的前瞻性观察研究 (OGIPRO)

2024-04-041
OA
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
2024-02-0124
OAAI